Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Filings indexed 504 across all filing types
Latest filing 2025-07-03 Share Issue/Capital Cha…
Country FR France
Listing Euronext Growth ALEUP

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 juin 2025
Share Issue/Capital Change Classification · 95% confidence The document is a standard regulatory disclosure regarding the total number of shares and voting rights as of June 30, 2025, in accordance with French commercial law (Article L. 233-8 II). This type of filing is a routine regulatory requirement for listed companies to update the market on their capital structure. Since it does not fit into specific categories like 'Share Issue' (which implies a change event) or 'Major Shareholding' (which implies a third-party notification), it falls under the general regulatory filing category.
2025-07-03 French
EUROPLASMA: Démenti à la suite de fausses informations publiées par le site Boursier.com
Regulatory Filings Classification · 95% confidence The document is a press release issued by Europlasma to formally deny false information regarding a new bond financing agreement reported by a third-party financial news site. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general regulatory announcement regarding company news and market integrity that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-06-30 French
EUROPLASMA: RÉDUCTION DE CAPITAL D’EUROPLASMA
Share Issue/Capital Change Classification · 95% confidence The document is a press release from Europlasma announcing a capital reduction (réduction de capital) by decreasing the nominal value of its shares. This is a structural change to the company's capital, which falls under the category of share issues or capital changes. While it mentions financial reports, the primary purpose of the document is to announce the specific corporate action of capital reduction.
2025-06-30 French
EUROPLASMA: TIRAGE DE 200 OBLIGATIONS CONVERTIBLES EN ACTIONS NOUVELLES POUR UN MONTANT NOMINAL DE 1M€
Share Issue/Capital Change Classification · 99% confidence The document is titled "Communiqué de presse" (Press Release) dated June 27, 2025, and announces the drawing down of convertible bonds ('TIRAGE DE 200 OBLIGATIONS CONVERTIBLES EN ACTIONS NOUVELLES'). This is a specific corporate action related to financing and capital structure changes, detailing the terms of the issuance and the associated risks (dilution, share price impact). This clearly falls under the category of Capital/Financing Update (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it concerns a specific financing event.
2025-06-27 French
EUROPLASMA: Mise à disposition du rapport annuel 2024
Report Publication Announcement Classification · 99% confidence The document is a press release dated June 16, 2025, titled "Mise à disposition du rapport annuel 2024" (Making available of the 2024 annual report). The core content explicitly states that the 'rapport annuel 2024' (2024 annual report) is now available on the company website. This structure—a short announcement informing the public that a major report (like the 10-K equivalent) has been published—fits the definition of a Report Publication Announcement (RPA). Although it mentions the Annual Report (10-K), the document itself is the announcement, not the full report, adhering to the 'MENU VS MEAL' rule. The document length (5922 chars) is relatively short for a full 10-K.
2025-06-16 French
EUROPLASMA: Résultats annuels 2024 et perspectives 2025
Earnings Release Classification · 100% confidence The document is titled "Résultats annuels 2024 et perspectives 2025" (Annual Results 2024 and 2025 Outlook) and explicitly states that it presents "ses comptes consolidés 2024 audités par le collège des Commissaires aux Comptes et arrêtés par le conseil d'administration (période du 1er janvier au 31 décembre 2024)". It contains detailed, audited financial tables covering the full fiscal year 2024 (revenues, EBITDA, net result, cash flow) broken down by segment. This content structure and the reference to full-year audited accounts strongly indicate an Annual Report, which corresponds to the 10-K filing type in the US context, or its equivalent comprehensive annual filing. Although the document is a press release format, its core content is the full annual financial disclosure, making '10-K' the most appropriate classification for a comprehensive annual report. FY 2024
2025-06-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.